Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Janice S Galler"'
Autor:
Suhaida A Selamat, Janice S Galler, Amit D Joshi, M Nicky Fyfe, Mihaela Campan, Kimberly D Siegmund, Keith M Kerr, Ite A Laird-Offringa
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21443 (2011)
BackgroundAberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases of tumor development is largely unknown. Delineating when abnormal DNA methylation arises may provide insight into the natural history of lung adenocarc
Externí odkaz:
https://doaj.org/article/b2eb146cafaf44aa9752ec800a46f547
Autor:
Meleeneh Kazarian, Ankur Patel, Ite A. Laird-Offringa, Janice S. Galler, Catherine L. Carpenter, Stephanie J. London, Jeffrey A. Tsou
Publikováno v:
Cancer Detection and Prevention. 32:292-299
Background : Previous experimental and laboratory studies have implicated antibodies against Hu proteins (anti-Hu) as a potential marker for small cell lung cancer (SCLC); there are no estimates of the association between anti-Hu and SCLC using a pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec6d09f79bcfda563e8fb5c2d8f6264
https://doi.org/10.1016/j.cdp.2008.06.006
https://doi.org/10.1016/j.cdp.2008.06.006
Publikováno v:
Disease Markers
Disease Markers, Vol 23, Iss 1-2, Pp 5-30 (2007)
Disease Markers, Vol 23, Iss 1-2, Pp 5-30 (2007)
Lung cancer, caused by smoking in ∼87% of cases, is the leading cause of cancer death in the United States and Western Europe. Adenocarcinoma is now the most common type of lung cancer in men and women in the United States, and the histological sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a70a27da206c938bb852a640d4fcac9b
https://doi.org/10.1155/2007/985474
https://doi.org/10.1155/2007/985474
Autor:
Ite A. Laird-Offringa, Janice S. Galler, Suhaida A. Selamat, M. Nicky Fyfe, Amit Joshi, Kimberly D. Siegmund, Mihaela Campan, Keith M. Kerr
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21443 (2011)
PLoS ONE
PLoS ONE
BackgroundAberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases of tumor development is largely unknown. Delineating when abnormal DNA methylation arises may provide insight into the natural history of lung adenocarc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a16d4a8aee9859270ce976734e9fbb2
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21731750/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21731750/?tool=EBI
Autor:
Peter W. Laird, Janice S. Galler, Paul P. Anglim, Kimberly D. Siegmund, Jeffrey A. Hagen, Sally Turla, Mihaela Campan, Michael Koss, Daniel J. Weisenberger, Ite A. Laird-Offringa
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 7, Iss 1, p 62 (2008)
Molecular Cancer, Vol 7, Iss 1, p 62 (2008)
Background Lung cancer is the leading cause of cancer death in men and women in the United States and Western Europe. Over 160,000 Americans die of this disease every year. The five-year survival rate is 15% – significantly lower than that of other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d580891fc893eaac80134be19e1c7fc
https://pubmed.ncbi.nlm.nih.gov/18616821
https://pubmed.ncbi.nlm.nih.gov/18616821
Publikováno v:
Journal of Thoracic Oncology. 2(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1802e11fed980b1464e35a160ecd9b0
Autor:
Wendy Cozen, Ite A. Laird-Offringa, Kimberly D. Siegmund, Jeffrey A. Tsou, Sally Turla, Peter W. Laird, Jeffrey A. Hagen, Michael Koss, Janice S. Galler
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 6, Iss 1, p 70 (2007)
Molecular Cancer, Vol 6, Iss 1, p 70 (2007)
Background Lung cancer is the number one cancer killer of both men and women in the United States. Three quarters of lung cancer patients are diagnosed with regionally or distantly disseminated disease; their 5-year survival is only 15%. DNA hypermet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae280ab8bb0743d41ea74dd5b50b4a80
http://europepmc.org/articles/PMC2206053
http://europepmc.org/articles/PMC2206053
Autor:
Anil Wali, Michael Koss, Sally Turla, Kimberly D. Siegmund, Jeffrey A. Tsou, Susan Groshen, Harvey I. Pass, Daniel J. Weisenberger, Mihaela Campan, Ite A. Laird-Offringa, Peter W. Laird, Wei Ye, Janice S. Galler
Publikováno v:
Lung Cancer. 54:S36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6613b502a88f17a7d2ebb94c34fef77
https://doi.org/10.1016/s0169-5002(07)70223-4
https://doi.org/10.1016/s0169-5002(07)70223-4